Status:
NOT_YET_RECRUITING
Intervention Study on Digital Health Management
Lead Sponsor:
Shanghai 10th People's Hospital
Conditions:
Hypertension
Hyperlipidemia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of this study is to construct a digital precision intervention system for cardiometabolism disorders based on the characteristics of the Chinese population, focusing on the core components of ...
Eligibility Criteria
Inclusion
- Age 18-65 years old; 2. Meet one of the following three conditions:
- Diastolic hypertension (systolic blood pressure \< 140 MMHG and diastolic blood pressure ≥90mmHg)
- Glycosylated hemoglobin (6.0-6.5)
- Obesity (BMI≥28kg/m²)
- Mild hyperlipemia: total cholesterol (TC) ≥5.2 mmol/L and \< 6.2 mmol/L, or low-density lipoprotein cholesterol (LDL-C) ≥3.4 mmol/L and \< 4.1 mmol/L 3. Antihypertensive or lipid-lowering medications have not been started 4. Use a smartphone and volunteer
Exclusion
- Complicated with chronic liver and kidney disease, coronary heart disease, heart failure and severe valvular disease
- Previous cardiovascular and cerebrovascular events
- Diastolic blood pressure ≥99mmHg
- Glycated hemoglobin ≥6.5
- Other life expectancy such as cancer is less than 5 years
- Participate in other clinical trials
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06949306
Start Date
July 1 2025
End Date
December 31 2030
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology,Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China, China